| |
|
|
|
|
|
|
|||
|
HEMATOPOIESIS
From INSERM U. 474, Hôpital de Port-Royal; INSERM
U. 479, Hôpital Bichat; Laboratoire d'hématologie,
Hôpital Trousseau, Paris, France; and INSERM U. 362, Institut
Gustave Roussy, Villejuif, France.
The gray platelet syndrome (GPS) is a rare congenital
bleeding disorder in which thrombocytopenia is associated with
increased platelet size and decreased The gray platelet syndrome (GPS) is an
inherited disorder of primary hemostasis with associated bleeding
tendency, thrombocytopenia, and classical abnormal platelet
morphology.1 The platelets appear characteristically gray
after Romanovsky staining as a result of an abnormally low Patients
The patients are the 3 children of a family with healthy parents. The
children are 2 heterozygous twins, aged 8 years at the time of
diagnosis, and their elder sister, aged 10 years. The older sister
exhibited thombocytopenia (70 × 109/L) with
recurrent ecchymosis and epistaxis since the age of 5 years. Up to the
age of 2 years, she had many pulmonary infections. Peripheral blood
smears showed that her platelets were large, agranular, and gray. In
addition her PMNs also displayed a gray cytoplasmic appearance instead
of their usual beige and granulous texture. On bone marrow smears,
erythroblastic and granulocytic lineages were normally represented but
only rare megakaryocytes (MKs) were present. The marrow specimen
obtained by biopsy showed normal cellularity and confirmed that the MKs
were reduced in number. A diffuse reticular fibrosis without increased
collagen was noticed. Kinetic studies of autologous platelets revealed a normal life span but platelet production was apparently only one
third of normal. Other investigations revealed similar biologic platelet and PMN patterns in her brother and her sister, both exhibiting thombocytopenia and prolonged bleeding times (Ivy tests: > 20 minutes).
Peripheral blood cells (platelets and PMNs) and cultured MKs from the 3 children were also studied. Ultrastructural examination of platelets
demonstrated the absence of normal Platelet number and morphology were normal in the parents and the
grandparents of these children. The karyotypes, studied by conventional
cytogenetic analysis, were normal.
Cells
For functional tests, PMNs were rapidly isolated at 4°C (to avoid activation) on 2% dextran T 500 (Pharmacia LKB, Uppsala, Sweden) in phosphate-buffered saline (PBS), then on a Ficoll-Isopaque gradient. After red blood cell lysis and washing with cold PBS, PMNs were adjusted to 106/mL in PBS lacking Ca++ and Mg++.9 Viability was always more than 99% in the trypan blue dye exclusion test. Antibodies Polyclonal rabbit antibodies were used for immunoelectron microscopy; anti-CD35 (Santa Cruz Biotechnology, Santa Cruz, CA), anti-vWF (Dakopatts, Glostrup, Denmark), antiglycocalicin (anti-GPIb),10 anti-P-selectin.11 (kind gifts from Dr Michael Berndt, Victoria, Australia) and antilactoferrin (Cappel Lab, Downington, PA) were used at 10 µg/mL. Goat antirabbit IgG coupled to 10 nm gold was purchased from British Biocell International (Cardiff, United Kingdom).Electron microscopy Normal PMNs, platelets, and MKs were prepared for immunoelectron microscopy as follows. After fixation, cells were washed 3 times with phosphate buffer, embedded in sucrose, and frozen in liquid nitrogen. Immunochemical reactions were performed on thin sections collected on grids according to the method of Bendayan.12 After a brief incubation of the sections with 0.1% BSA and 15% normal goat serum, they were labeled with the polyclonal rabbit antibodies diluted in Tris-buffered saline (TBS) containing 1% BSA and 4% normal goat serum for 2 hours at 22°C, washed 3 times with TBS containing 0.1% BSA, and then incubated with goat antirabbit-gold (10 nm) for 1 hour at 22°C. Double-labeling experiments were performed according to Slot and Geuze.13 The sections were counterstained with uranyl acetate and lead citrate. Samples were observed on a Philips 450 CM 10 electron microscope (Eindoven, The Netherlands).Leukocyte alkaline phosphatase cytochemistry Freshly prepared blood smears from the 3 patients, from their parents, and from a control subject were fixed in a solution of formol and methanol (1:9) for 1 minute, then covered with a mixture containing -naphtyl-phosphate Na (Sigma Chemical), 0.1 g and Fast Garnet (Sigma
Chemical) 0.1 g, in propanediol buffer (25 mL) and HCl N/10 (5 mL)
added to distilled water (70 mL) for 25 minutes. In each sample,
at least 100 PMNs were examined and the staining intensity of each of
them was scored from 0 to 4 (0, no staining; 1, light beige
cytoplasm; 2, deep beige cytoplasm; 3, brown staining in part of the
cytoplasm; 4, homogeneously dark brown cytoplasm).
Expression of CD11b/CD18 and CD35 at the PMN surface Heparinized blood was placed on ice and analyzed immediately. Whole blood samples were either kept on ice or incubated with PBS or N-formyl-methyonyl-leucyl-phenylalanine (fMLP; 10 6 M), at 37°C for 5 minutes. To study CD11b, CD18,
and CD35 expression, samples (100 µL) from each patient were then
incubated with phycoerythrin (PE)-conjugated monoclonal mouse antihuman
CD11b antibody (Dakopatts), fluorescein isothiocyanate
(FITC)-conjugated monoclonal mouse antihuman CD18 antibody (Becton
Dickinson, Immunocytometry Systems, San Jose, CA), or FITC-conjugated
monoclonal mouse antihuman CD35 antibody (Immunotech, Marseilles,
France) for 30 minutes at 4°C. Red cells were lysed with FACS lysing
solution. After one wash with ice-cold PBS, the cells were resuspended
in 1% paraformaldehyde-PBS and kept on ice until analysis. Nonspecific
antibody binding was determined on cells incubated with the same
concentration of an irrelevant antibody of the same isotype.
PMN functions Activity of reduced nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase was tested as follows. The nitroblue tetrazolium reduction assay was applied to whole blood in the presence of endotoxin (lipopolysaccharides, Escherichia coli O 55:B5, 10 µg/mL for 15 minutes) or Staphylococcus epidermidis (107 colony-forming units (CFUs)/mL for 15 minutes). After red blood cell lysis, leukocytes were cytospun and stained with fuchsin, and the percentage of PMNs containing dark blue formazan precipitates was counted microscopically.The luminol-amplified chemiluminescence assay was performed after
stimulation of isolated PMNs with either fMLP (10 We also measured H2O2 production using a flow cytometric assay according to Bass and coworkers.14,15 This technique is based on the oxidation of the nonfluorescent 2',7'-dichlorofluorescin into highly fluorescent dichlorofluorescein (DCF), by H2O2 produced by PMA-stimulated PMNs. Spontaneous and directed migration under agarose, toward fMLP
(10 Flow cytometry analysis Flow cytometry analysis was performed using a Becton Dickinson FACScan (Becton Dickinson Immunocytometry Systems) with a 15-mW, 488-nm argon laser. Forward and side scatters were used to identify the granulocyte population and to gate out other cells and debris. The purity of the gated cells was assessed by using FITC- or PE-conjugated CD3, CD45, CD14, and CD15 antibodies (Becton Dickinson). The green fluorescence of FITC-conjugated antibodies and DCF was recorded from 515 to 545 nm; the red fluorescence of PE-conjugated anti-CD11b was recorded from 563 to 607 nm. In all cases, unstained cells were used and the photomultiplier settings were adjusted so that the unstained cell population appeared in the lower left-hand corner of the fluorescence display. All the results were obtained with a constant photomultiplier gain. The data were analyzed using LYSIS II software (Becton Dickinson) and the mean fluorescence intensity (MFI) was used to quantify the responses. The results were compared to the normal ranges obtained from members of the laboratory staff as controls.
Blood smears Light microscopic examination of the blood smears of the 3 children was performed. Platelets displayed a characteristic gray color confirming the diagnosis of GPS. Furthermore, the PMN cytoplasm background staining was also gray with a degranulated appearance compared with normal PMNs (Figure 1A,B). The blood smears from the 2 parents were normal and platelets and PMNs displayed normal color.
PMN cytochemical and ultrastructural examination Because of the gray appearance on the smears of the PMN cytoplasm, the different neutrophil granule compartments were explored in these patients. The cytochemical detection of the leukocyte enzyme alkaline phosphatase (a specific component of the membrane of secretory vesicles) was consistently and strongly decreased compared to normal PMNs (Figure 1C,D), with a mean score of 5, 7, and 5, respectively, compared against a control mean of 62.Myeloperoxidase (MPO)-positive primary granules were normally present,
as attested by cytochemical reactions observed by electron microscopy.
Immunolabeling for lactoferrin showed a strong decrease in secondary
granules in the 2 patients whose PMNs could be studied by electron
microscopy (Figure 2). The ratio of
secondary/primary granules was diminished in these patients:
control = 60%, patient Ju = 26%, patient Me = 21%. Control
immunolabeling was performed by omitting the primary antibody in the
reaction that led to the absence of gold particles on the structures.
PMN flow cytometry and functional studies Because alkaline phosphatase is a component of the membrane of secretory vesicles, which was undetectable in the 3 patients' PMNs,17,18 we investigated the distribution of the other specific components of secretory vesicles the complement receptor
CD35, which is normally restricted to the membrane of secretory
vesicles; the integrins CD11b/CD18, which are expressed within both
secretory vesicles and specific granules. The expression of
CD35, CD11b, and CD18 (Table 1) was
increased in the patients at the basal state when compared to controls.
The membrane expression for those proteins was maximal on unstimulated
neutrophils and did not increase on stimulation by fMLP as is the case
in normal neutrophils. Interestingly, even if CD11b and CD18
expressions were highly expressed at the membrane in the PMN basal
state, and barely increased after fMLP stimulation, the level of CD11b
and CD18 at the membrane did not reach more than 30% of the control
levels. The high basal expression of these receptors in the patients
could not be explained by in vivo or in vitro PMN activation, because
L-selectin expression remained in the normal range:
controls = 166 ±16; patient Me = 137; patient
Ju = 145.
Functional studies of PMN leukocytes were normal. Oxidase activity after PMA, fMLP, endotoxin, and bacterial stimulation as well as spontaneous and oriented migration were studied in the 3 children and did not differ from normal controls (data not shown). Electron microscopy of platelets and MKs The platelets from the 3 children displayed similar ultrastructure. Platelet size was heterogeneous, and many platelets were larger than a red blood cell or a small lymphocyte. The most striking morphologic abnormality was the lack of normal -granules
and prominent vacuolization of the cytoplasm (Figure
3A). Membrane complexes, which represent
abnormally distributed intracellular membrane, were also observed
(Figure 3B).
Intracellular trafficking of
Then, intracellular trafficking of
Control immunolabeling was performed by omitting the primary antibody in the reaction, which led to the absence of gold particles on the structures.
This study describes a new family of 3 children with GPS. GPS is a
rare congenital disorder, which can be either sporadic or inherited in
an autosomal dominant fashion according to the reported observation of
a large Japanese family with 24 members affected by the
disease.19 The family presented here, with 2 healthy
parents and the 3 affected children, suggests that the genetic
transmission might also be recessive. Moreover, another family reported
earlier displayed a similar inheritance pattern with healthy parents
and the 2 children, a brother and a sister, with
GPS.2,20,21 Nevertheless, another mode of inheritance cannot be excluded, such as germinal mosaicism, variable genic penetration, or underexpression of a gene due to an unidentified control mechanism. The We demonstrate here that vWF is indeed abundantly synthesized, but
appears to be misdirected into the lumen of the demarcation membrane
system. This protein seems to be secreted into the extracellular medium
instead of being packaged (or efficiently retained) in the
Although MKs and endothelial cells share many common processing steps
of synthesis storage and regulated release of vWF within We have also extensively studied PMNs of the 3 children because of the gray staining with Romanovsky stain. Interestingly, a retrospective study of the blood smears from 2 previously published cases indicated the same gray color of PMNs. Due to the similar staining properties between platelets and PMNs, we have investigated the PMN granules. At least 3 well-defined secretory organelles have been described in PMNs: primary granules that contain MPO, secondary granules that contain lactoferrin, and secretory vesicles that contain the alkaline phosphatase and CD35 receptor in their membrane and plasma proteins (albumin) in their lumen.17,38,39 The 3 children with GPS presented an impairment of the secretory vesicle and secondary granule compartments, whereas MPO-containing primary granules were normally present. The cytochemical activity of the leukocyte alkaline phosphatase was examined in the 3 GPS children, their 2 parents, and the 2 previously reported patients.2 In the 5 patients this enzymatic cytochemical activity was very low, only barely detectable, whereas it was normal in the parents. In addition, secretory vesicles provide an intracellular CD35 reservoir, from which this membrane protein may be recruited to the cell surface after fMLP stimulation.17 Our flow cytometric studies showed a maximal CD35 expression at the surface of the patient PMNs, in their resting state. This expression did not increase after fMLP stimulation. The high basal expression of CD35 without up-regulation suggests that during granulopoiesis, newly synthesized CD35 was not retained in the secretory vesicles, but was routed to the plasma membrane. This is in accordance with the findings that a promyelocytic cell line, NB4 cells, forced to differentiate into neutrophils with dimethyl sulfoxide or retinoic acid, lacks specific granules, whereas some of the cell line's endogenous protein content localizes to the plasma membrane.40,41 The integrin CD11b/CD18 is present in both secretory vesicles and specific granules. It is also up-regulated by degranulation in a hierarchical manner, playing a key role in the different steps leading to PMN infiltration of inflammatory sites. In the children with GPS, CD11b/CD18 is also highly expressed at the membrane in the basal resting state. This is in accordance with the ultrastructural observation of a decrease in specific granules.17 The high basal membrane expression of CD35, CD11b/CD18 was not due to PMN activation because L-selectin was not decreased. Indeed, this adhesion molecule is constitutively expressed at the PMN plasma membrane, and on activation, it is shed from the membrane by proteolysis. The importance of the specific granules in neutrophil function has been shown in patients who lack specific granules.42 These patients are susceptible to repeated skin and respiratory infections and have defective neutrophil chemotaxis and adhesion. To our knowledge, the clinical consequences of secretory vesicle defect in patients has not been described. In the present cases, one of the children has suffered many respiratory infections but not the others. This study describes a new association between thrombocytopenia and PMN abnormalities. Noteworthy, such an association is present in the May-Hegglin syndrome,43 Fechtner syndrome (a variant of Alport syndrome with leukocyte inclusions and macrothrombocytopenia),44 and Chediak-Higashi syndrome.45 The observation that the secretory compartments of 2 different lineages are affected by the same pathologic process in GPS strongly suggests a similar molecular defect in the common hematopoietic precursor.
The authors gratefully acknowledge Dr Fadila Souni for the light microscopic work on PMNs, Pr Jacques Caen for allowing the retrospective study of the PMNs of 2 GPS patients, Dr Paul Harrison for improving the manuscript, and Dr Paul-Henri Romeo for his constant support.
Submitted July 13, 2000; accepted April 24, 2001.
The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734.
Reprints: Elisabeth M. Cramer. INSERM U.474, Maternité Port-Royal, 5ème étage, 123 Boulevard de Port-Royal, Paris 75014, France; e-mail: elisabeth{at}cochin.inserm.fr.
1. Raccuglia G. Gray platelet syndrome: a variety of qualitative platelet disorders. Am J Med. 1971;51:818-828[CrossRef][Medline] [Order article via Infotrieve].
2.
Cramer EM, Vainchenker W, Vinci G, Guichard J, Breton-Gorius J.
Gray platelet syndrome: immunoelectron microscopic localisation of fibrinogen and von Willebrand factor in platelets and megakaryocytes.
Blood.
1985;66:1309-1316
3.
Rosa JP, George JN, Bainton DF, Nurden AT, Caen JP, McEver RP.
Gray platelet syndrome: demonstration of
4.
Weiss HJ, Witte LD, Kaplan KL, et al.
Heterogeneity in storage pool deficiency: studies on granule bound substances in 18 patients including variants deficient in alpha granules, platelet factor 4, beta-thromboglobulin and platelet derived growth factor.
Blood.
1979;54:1296-1319
5.
Hayward CP, Cramer EM, Kane WH, et al.
Studies of a second family with the Quebec platelet disorder: evidence that the degradation of the
6.
Harrison P, Cramer EM.
Platelet
7.
Harrison P, Savidge GF, Cramer EM.
Annotation: the origin and physiological relevance of
8.
Cramer EM, Norol F, Guichard J, et al.
Ultrastructure of platelet formation by human megakaryocytes cultured with the Mpl ligand.
Blood.
1997;89:2336-2346
9.
Dang PM, Dewas C, Gaudry M, et al.
Priming of human neutrophil respiratory burst by granulocyte/macrophage colony-stimulating factor (GM-CSF) involves partial phosphorylation of p47(phox).
J Biol Chem.
1999;274:20704-20708
10.
Berger G, Masse JM, Cramer EM.
Alpha-granule membrane mirrors the platelet plasma membrane and contains the glycoproteins Ib, IX, and V.
Blood.
1996;87:1385-1396
11.
Gamble JR, Skinner MP, Berndt MC, Vadas MA.
Prevention of activated neutrophil adhesion to endothelium by soluble adhesion protein GMP140.
Science.
1990;249:414-417 12. Bendayan M, Roth J, Perrelet A, Orci L. Quantitative immunocytochemical localization of pancreatic secretory proteins in subcellular compartments of the rat acinar cell. J Histochem Cytochem. 1980;28:149-160[Abstract]. 13. Slot JW, Geuze HJ. Immunoelectron microscopic exploration of the Golgi complex. J Histochem Cytochem. 1983;31:1049-1056[Abstract]. 14. Bass DA, Parce JW, Dechatelet LR, Szejda P, Seeds MC, Thomas M. Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J Immunol. 1983;130:1910-1917[Abstract].
15.
Elbim C, Prevot MH, Bouscarat F, et al.
PMN from HIV-infected patients show enhanced activation, diminished fMLP-induced L-selectin shedding and an impaired oxidative burst after cytokine priming.
Blood.
1994;84:2759-2766 16. Amar M, Amit N, Pham Huu T, et al. Production by K562 cells of an inhibitor of adherence-related functions of human neutrophils. J Immunol. 1990;144:4749-4756[Abstract]. 17. Sengelov H, Kjeldsen L, Kroeze W, Berger M, Borregaard N. Secretory vesicles are the intracellular reservoir of complement receptor 1 in human neutrophils. J Immunol. 1994;153:804-810[Abstract].
18.
Witko-Sarsat V, Cramer EM, Hieblot C, et al.
Presence of proteinase 3 in secretory vesicles: evidence of a novel, highly mobilizable intracellular pool distinct from azurophil granules.
Blood.
1999;94:2487-2496 19. Mori K, Suzuki S, Sugai K. Electron microscopic and functional studies on platelets in gray platelet syndrome. Tohoku J Exp Med. 1984;143:261-287[Medline] [Order article via Infotrieve].
20.
Levy-Toledano S, Caen JP, Breton-Gorius J, et al.
Gray platelet syndrome:
21.
Breton-Gorius J, Vainchenker W, Nurden A, Levy-Toledano S, Caen J.
Defective
22.
Cramer EM, Debili N, Martin JF, et al.
Uncoordinated expression of fibrinogen compared with thrombospondin and von Willebrand factor in maturing human megakaryocytes.
Blood.
1989;73:1123-1129
23.
Harrison P, Wilbourn BR, Debili N, et al.
Uptake of plasma fibrinogen into the
24.
Handagama P, Rappolee DA, Werb Z, Levin J, Bainton DF.
Platelet 25. de Larouziere V, Brouland JP, Souni F, Drouet L, Cramer E. Inverse immunostaining pattern for synthesized versus endocytosed alpha-granule proteins in human bone marrow megakaryocytes. Br J Haematol. 1998;101:118-125. 26. Roussi J, Drouet L, Sigman J, et al. Absence of incorporation of plasma von Willebrand factor into porcine platelet alpha-granules. Br J Haematol. 1995;90:661-668[Medline] [Order article via Infotrieve].
27.
Heijnen HF, Debili N, Vainchencker W, Breton-Gorius J, Geuze HJ, Sixma JJ.
Multivesicular bodies are an intermediate stage in the formation of platelet alpha-granules.
Blood.
1998;91:2313-2325
28.
Youssefian T, Cramer EM.
Multivesicular bodies as a sorting compartment for alpha and dense granule components.
Blood.
2000;95:4004-4007 29. Rindler MJ. Biogenesis of storage granules and vesicles. Curr Opin Cell Biol. 1992;4:616-622[CrossRef][Medline] [Order article via Infotrieve]. 30. Schick BP, Pestina TI, San Antonio JD, Stenberg PE, Jackson CW. Decreased serglycin proteoglycan size is associated with the platelet alpha granule storage defect in Wistar Furth hereditary macrothrombocytopenic rats: serglycin binding affinity to type I collagen is unaltered. J Cell Physiol. 1997;172:87-93[CrossRef][Medline] [Order article via Infotrieve]. 31. Balch WB. Small GTP binding proteins in vesicular transport. Trends Biochem Sci. 1990;15:473-477[CrossRef][Medline] [Order article via Infotrieve]. 32. Chavrier P, Goud B. The role of ARF and Rab GTPases in membrane transport. Curr Opin Cell Biol. 1999;11:466-475[CrossRef][Medline] [Order article via Infotrieve].
33.
Wagner D, Marder V.
Biosynthesis of von Willebrand protein by human endothelial cells: processing steps and their intracellular localization
J Cell Biol.
1984;99:2123-2130
34.
Gebrane-Younes J, Cramer EM, Orcel J, Caen JP.
Gray platelet syndrome: dissociation between abnormal sorting in megakaryocyte 35. Disdier M, Morrissey JH, Fugate RD, Bainton DF, McEver RP. Cytoplasmic domain of P-selectin (CD62) contains the signal for sorting into the regulated secretory pathway. Mol Biol Cell. 1992;3:309-321[Abstract]. 36. Castro-Malaspina H. Pathogenesis of myelofibrosis: role of ineffective megakaryopoiesis and megakaryocyte components. Prog Clin Biol Res. 1984;154:427-454[Medline] [Order article via Infotrieve].
37.
Schmitt A, Jouault H, Drouin A, Guichard J, Wendling F, Cramer EM.
Pathological interaction between megakaryocytes and PMN leukocytes in myelofibrosis.
Blood.
2000;96:1342-1347 38. Borregaard N, Lollike K, Kjeldsen L, et al. Human neutrophil granules and secretory vesicles. Eur J Haematol. 1993;4:187-198.
39.
Borregaard N, Cowland JB.
Granules of the human neutrophilic polymorphonuclear leukocyte.
Blood.
1997;89:3503-3521 40. Gregoire C, Welch H, Astarie-Dequeker C, Maridonneau-Parini I. Expression of azurophil and specific granule proteins during differentiation of NB4 cells in neutrophils. J Cell Physiol. 1998;175:203-210[CrossRef][Medline] [Order article via Infotrieve].
41.
Gianni M, Terao M, Zanotta S, Barbui T, Rambaldi A, Garattini E.
Retinoic acid and granulocyte colony-stimulating factor synergistically induce leukocyte alkaline phosphatase in acute promyelocytic leukemia cells.
Blood.
1994;83:1909-1921 42. Ganz T, Metcalf JA, Gallin JI, Boxer LA, Lehrer RI. Microbicidal/cytotoxic proteins of neutrophils are deficient in two disorders: Chediak-Higashi syndrome and "specific" granule deficiency. J Clin Invest. 1988;82:552-556. 43. Noris P, Spedini P, Belletti S, Magrini U, Balduini CL. Thrombocytopenia, giant platelets, and leukocyte inclusion bodies (May-Hegglin anomaly): clinical and laboratory findings. Am J Med. 1998;104:355-360[CrossRef][Medline] [Order article via Infotrieve].
44.
Peterson LC, Rao KV, Crosson JT, White JG.
Fechtner syndrome, a variant of Alport's syndrome with leukocyte inclusions and macrothrombocytopenia.
Blood.
1985;65:397-406 45. Introne W, Boissy RE, Gahl WA. Clinical, molecular, and cell biological aspects of Chediak-Higashi syndrome. Mol Genet Metab. 1999;68:283-303[CrossRef][Medline] [Order article via Infotrieve].
© 2001 by The American Society of Hematology.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
B. Lo, L. Li, P. Gissen, H. Christensen, P. J. McKiernan, C. Ye, M. Abdelhaleem, J. A. Hayes, M. D. Williams, D. Chitayat, et al. Requirement of VPS33B, a member of the Sec1/Munc18 protein family, in megakaryocyte and platelet {alpha}-granule biogenesis Blood, December 15, 2005; 106(13): 4159 - 4166. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Nurden, M. Jandrot-Perrus, R. Combrie, J. Winckler, V. Arocas, C. Lecut, J.-M. Pasquet, T. J. Kunicki, and A. T. Nurden Severe deficiency of glycoprotein VI in a patient with gray platelet syndrome Blood, July 1, 2004; 104(1): 107 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Drachman Inherited thrombocytopenia: when a low platelet count does not mean ITP Blood, January 15, 2004; 103(2): 390 - 398. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2001 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||